NASDAQ OMX

Nasdaq Corporate Solutions Unveils Nasdaq Boardvantage®, its Next Generation Board Portal and Team Collaboration Software

Del

Will Leverage Best Features from Current Nasdaq Platforms and Combine Advancements in Cloud-based Collaboration Technology

NEW YORK, Oct. 02, 2017 (GLOBE NEWSWIRE) -- Nasdaq Corporate Solutions, a business of Nasdaq, Inc. (Nasdaq:NDAQ), today unveils its next generation board portal and team collaboration software, Nasdaq Boardvantage. Nasdaq Boardvantage is available as a web-based, tablet and mobile solution and offers enhanced governance and collaboration solutions for C-suite leadership, board members, corporate secretaries, and other corporate and private organization professionals beyond the boardroom. The new product will introduce a suite of new services and features as well as combine the best features from two of Nasdaq Corporate Solutions' most popular products: Nasdaq Directors Desk® and Boardvantage MeetX®.

Photos accompanying this announcement are available at

http://www.globenewswire.com/NewsRoom/AttachmentNg/20640da9-ffc5-4844-bf56-73ba4f18146f

http://www.globenewswire.com/NewsRoom/AttachmentNg/5f431a88-2891-4223-a55d-e2e735637149

"Our board portal and team collaboration solutions are a critical foundation of the Nasdaq Corporate Solutions product offering as well as any company's governance framework," said Stacie Swanstrom, Executive Vice President and Head of Nasdaq Corporate Solutions. "We are intensely focused on the needs of corporate boards and leadership teams and, with the release of Nasdaq Boardvantage, stand proud to offer clients with a next generation software solution that helps further strengthen governance, engagement and collaboration throughout their organizations."

Key features of Nasdaq Boardvantage planned for release include:

  • A flexible and updated user interface with enhanced functions to the administration module;
  • Advanced search, featuring improved responsiveness and granular criteria;
  • Improved management of version control and alerting; and
  • Collaboration with in-document discussions, annotations, votes and e-signatures.

Nasdaq Corporate Solutions has observed a growing global trend driving increased demand for our board portal tools, notably the need to collaborate and share confidential information and documents across internal and external teams in a highly secured environment. Many C-suite executives who already use Nasdaq's board portal tools for board-level collaboration are now cascading that capability down into their organizations, all through a single sign-on service.  Nasdaq Boardvantage has been specifically designed to make it easy for clients to create multiple team spaces for different business teams to use the product to streamline file sharing, editing and e-signatures.

To learn more about Nasdaq Boardvantage please visit: http://business.nasdaq.com/intel/Boardvantage/index.html

The Nasdaq Corporate Solutions business of Nasdaq, Inc. has continuously invested in enhancements to its board portal and collaboration platforms to support better workflows in response to client feedback. In June 2017, Nasdaq Corporate Solutions announced a partnership with the Center for Board Excellence to offer a suite of corporate governance tools including, board assessments and compliance questionnaires. In August 2017, Nasdaq Corporate Solutions announced the addition of two Ontario-based data centers in response to growing demand for its board portal solutions in Canada. Over 100,000 corporate users in over 70 countries rely on Nasdaq Corporate Solutions for corporate governance and team collaboration software. Nasdaq Corporate Solutions is proud of its unique user universe, which includes CEOs, corporate secretaries, business leaders, general counsels, chief risk officers, directors, and board chairs from a diverse mix of corporate clients including: public and private companies, non-profit organizations, law firms, private equity firms, and hospital systems, among others. 

About Nasdaq: 

Nasdaq (Nasdaq:NDAQ) is a leading global provider of trading, clearing, exchange technology, listing, information and public company services. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 90 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to approximately 3,900 total listings with a market value of approximately $12 trillion. To learn more, visit: http://business.nasdaq.com.

This communication and the content found by following any link herein are being provided to you by Nasdaq Corporate Solutions, a business of Nasdaq, Inc. ("Nasdaq"), for informational purposes only. Nasdaq makes no representation or warranty with respect to this communication or such content and expressly disclaims any implied warranty under law. Nasdaq, the Nasdaq logo, Nasdaq Corporate Solutions and Boardvantage are registered and unregistered trademarks, or service marks, of Nasdaq, Inc. or its subsidiaries in the U.S. and other countries. © Nasdaq, Inc. 2017. All rights reserved.

Nasdaq Media Contact:

Will Briganti
(212) 231-5012
william.briganti@nasdaq.com




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Nasdaq via Globenewswire

Om NASDAQ OMX

NASDAQ OMX
NASDAQ OMX
One Liberty Plaza - 165 Broadway
NY 10006 New York

+1 212 401 8700http://www.nasdaqomx.com

NASDAQ OMX (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.

Følg saker fra NASDAQ OMX

Registrer deg med din epostadresse under for å få de nyeste sakene fra NASDAQ OMX på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra NASDAQ OMX

Barings Supports New Mountain Capital Investment in DRB Systems17.10.2017 16:30Pressemelding

CHARLOTTE, N.C., Oct. 17, 2017 (GLOBE NEWSWIRE) -- Barings, one of the world's leading asset management firms, announced today that it served as a Joint Lead Arranger on a Senior Secured Credit Facility to support New Mountain Capital's acquisition of DRB Systems LLC.                                                               Founded in 1984 and based in Akron, Ohio, DRB Systems is the leading provider of turnkey technology solutions used to enhance the operational efficiency of car wash sites across the U.S.  DRB's integrated technology offering includes hardware and software used in point-of-sale and tunnel control systems as well as ancillary modules to support marketing, human resources, and business analytics. "New Mountain Capital is pleased to have completed its investment in DRB Systems," said Jack Qian, Director of New Mountain Capital. Laura Holson, Head of Capital Markets at New Mountain added, "We deeply value Barings' support as a financing pa

Crown Bioscience to Showcase Scientific Expertise in Preclinical Evaluation of Investigational Cancer Compounds17.10.2017 16:12Pressemelding

SANTA CLARA, Calif., Oct. 17, 2017 (GLOBE NEWSWIRE) -- Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE:ticker 6554) and a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research, will showcase their scientific expertise at this year's American Association for Cancer Research's International Conference on Molecular Targets and Cancer Therapeutics (AACR-NCI-EORTC) October 26th through the 30th. CrownBio's scientists will present 13 scientific posters describing their latest research efforts, including generation of novel models for combinatory chemotherapy and immunotherapy studies, creation of 3D screening panels for improved efficacy assessments, demonstration of a checkpoint immunotherapy modulating intestinal microbiota, among other innovative developments in cancer therapeutics and preclinical pharmacology evaluation. On

Oxford Immunotec Schedules Third Quarter 2017 Earnings Release and Conference Call for October 31, 201717.10.2017 15:15Pressemelding

OXFORD, United Kingdom and MARLBOROUGH, Mass., Oct. 17, 2017 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company focused on developing and commercializing proprietary tests for the management of underserved immune-regulated conditions, today announced that it plans to release third quarter 2017 financial results prior to market open on Tuesday, October 31, 2017.  Dr. Peter Wrighton-Smith, Chief Executive Officer, and Rick Altieri, Chief Financial Officer, will host a conference call to review the Company's results at 8:00 a.m. Eastern Time the same day. The call will be concurrently webcast. To listen to the conference call on your telephone, please dial (855) 363-5047 for United States callers and +1 (484) 365-2897 for international callers and reference confirmation code 99539511, approximately ten minutes prior to start time.  To access the live audio webcast or subsequent archived recording, visit the Investor Relations se

World Conference on Lung Cancer Tuesday Press Conference: Evidence to Support Innovative Lung Cancer Interventions17.10.2017 08:16Pressemelding

YOKOHAMA, Japan, Oct. 17, 2017 (GLOBE NEWSWIRE) -- Today's press conference at the International Association for the Study of Lung Cancer (IASLC) 18th World Conference on Lung Cancer (WCLC) featured groundbreaking findings in the study of both small cell and non-small cell lung cancer. The studies presented covered broad research areas, from confirmation of existing classification criteria to ensuring viability of evidence to supporting the use of specific interventions. Biopsy specimen found to be reliable for evaluating DLL3 expression in small cell lung cancer Small cell lung cancer (SCLC) biopsy specimen was found to be reliable material for evaluating DLL3 expression; high levels of DLL3 in SCLC are correlated with poor survival trends. These results may lead to further evaluation of the scoring system for predicting DLL3-targeted therapeutic efficacy and clinical significance of DLL3 expression in high-grade pulmonary neuroendocrine carcinomas.

New Era Launches Direct-to-Consumer eCommerce Site Built by EPAM and Powered with SAP Hybris17.10.2017 06:01Pressemelding

New Site Expands Headwear and Apparel Offering with Immersive, Omnichannel Experience NEWTOWN, Pa., Oct.  17, 2017  (GLOBE NEWSWIRE) -- EPAM Systems, Inc. (NYSE:EPAM), a leading global provider of digital platform engineering and software development services, and New Era, a global headwear brand rooted in sports, today announced the launch of New Era's first direct-to-consumer website, neweracap.com. New Era's B2B business remains strong, and the company is now putting an emphasis on selling its products directly to customers and expanding its offering into the lifestyle market. The new site offers products for seasoned athletes and sports fans, as well as street and lifestyle consumers. "In an age where businesses cannot tolerate lengthy, scope changing technology projects, EPAM quickly established themselves as the standout partner for us to tackle this ambitious initiative," said Lorenz Gan, Global Vice President, Information Technology, New Era. "Whilst this p

CP Kelco Appoints Didier Viala as New President16.10.2017 15:00Pressemelding

ATLANTA, Oct. 16, 2017 (GLOBE NEWSWIRE) -- CP Kelco, a leading global producer of specialty hydrocolloid solutions, announced today that Didier Viala has been appointed President, effective October 1, 2017. Viala replaces Donald Rubright, who served as CP Kelco President since 2006 and will retire at the end of 2017. Viala has also joined the CP Kelco Board of Directors. "As a market leader supplying high-quality hydrocolloid products for a range of foods and beverages, consumer products and industrial applications, CP Kelco will continue to invest in capacity additions, new product and applications development, strategic raw material sourcing, quality and safety management, and sustainability initiatives to support our customers' innovation efforts and growth strategies," Viala said. Over the course of more than 25 years with CP Kelco and its predecessor companies, Viala held leadership roles across a broad spectrum of critical areas, including innovat

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom